Moore Capital Management, LP Kezar Life Sciences, Inc. Transaction History

Moore Capital Management, LP

  • $4.85 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$3.13 - $7.31 $125,200 - $292,400
-40,000 Reduced 32.0%
85,000 $266,000
Q4 2022

Feb 14, 2023
SELL
$6.39 - $8.8 $351,181 - $483,630
-54,958 Reduced 30.54%
125,000 $880,000
Q3 2022

Nov 14, 2022
SELL
$7.99 - $10.75 $395,265 - $531,802
-49,470 Reduced 21.56%
179,958 $1.55 Million
Q2 2022

Aug 15, 2022
BUY
$4.58 - $17.13 $1.05 Million - $3.93 Million
229,428 New
229,428 $1.9 Million

Others Institutions Holding KZR

# of Institutions
62
Shares Held
38.4M
Call Options Held
13.8K
Put Options Held
600
View Full List

About Kezar Life Sciences, Inc.

KZR Quotes by TradingView
  • Ticker KZR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,369,504
  • Market Cap $510M
  • Description
  • Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...
More about KZR
Track This Portfolio

Track Moore Capital Management, LP Portfolio

Follow Moore Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Moore Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email